Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1988 Sep;56(9):2450–2457. doi: 10.1128/iai.56.9.2450-2457.1988

Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines.

M F Barile 1, D K Chandler 1, H Yoshida 1, M W Grabowski 1, S Razin 1
PMCID: PMC259587  PMID: 3137170

Abstract

A hamster immunization challenge assay described in the accompanying paper (M. F. Barile, D. K. F. Chandler, H. Yoshida, M. W. Grabowski, R. Harasawa, and S. Razin, Infect. Immun. 56:2443-2449, 1988) was used to examine protection against Mycoplasma pneumoniae disease by passive immunization and to evaluate the protective potency of a Formalin-inactivated whole-cell and a cell extract M. pneumoniae vaccine. Passive immunization with a globulin fraction of hyperimmune mule antiserum to M. pneumoniae provided hamsters some protection against the challenge. When hamsters were actively immunized, a single dose of Formalin-inactivated vaccine provided only minimal protection, whereas multiple doses of this vaccine, particularly when combined with adjuvant, provided good protection. A single dose of the cell extract vaccine did not protect animals, but two doses caused a marked reduction of disease when a priming dose was given intraperitoneally, followed by a booster dose intratracheally. The correlation between the level of metabolism inhibition antibodies to M. pneumoniae in the sera of vaccinated hamsters and the degree of protection as measured by reduction of lung pathological scores and colonization was poor, indicating that seroconversion rates for metabolism inhibition antibodies are not by themselves adequate to measure the potency of M. pneumoniae vaccines.

Full text

PDF
2450

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen P. Z., Prescott B. Immunochemical studies on a Mycoplasma pneumoniae polysaccharide fraction: cross-reactions with type 23 and 32 antipneumococcal rabbit sera. Infect Immun. 1978 May;20(2):421–429. doi: 10.1128/iai.20.2.421-429.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barile M. F., Chandler D. K., Yoshida H., Grabowski M. W., Harasawa R., Ahmed O. A. Hamster challenge potency assay for evaluation of Mycoplasma pneumoniae vaccines. Isr J Med Sci. 1981 Jul;17(7):682–686. [PubMed] [Google Scholar]
  3. Barile M. F., Chandler D. K., Yoshida H., Grabowski M. W., Harasawa R., Razin S. Parameters of Mycoplasma pneumoniae infection in Syrian hamsters. Infect Immun. 1988 Sep;56(9):2443–2449. doi: 10.1128/iai.56.9.2443-2449.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baseman J. B., Cole R. M., Krause D. C., Leith D. K. Molecular basis for cytadsorption of Mycoplasma pneumoniae. J Bacteriol. 1982 Sep;151(3):1514–1522. doi: 10.1128/jb.151.3.1514-1522.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bienenstock J., McDermott M., Befus D., O'Neill M. A common mucosal immunologic system involving the bronchus, breast and bowel. Adv Exp Med Biol. 1978;107:53–59. doi: 10.1007/978-1-4684-3369-2_7. [DOI] [PubMed] [Google Scholar]
  6. Brown R. C., Hendley J. O., Gwaltney J. M., Jr Mycoplasma pneumoniae vaccine: antigenicity of buffered antigens in volunteers. Infect Immun. 1972 May;5(5):657–661. doi: 10.1128/iai.5.5.657-661.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brunner H., Feldner J., Bredt W. Effect of monoclonal antibodies to the attachment-tip on experimental Mycoplasma pneumoniae infection of hamsters. A preliminary report. Isr J Med Sci. 1984 Sep;20(9):878–881. [PubMed] [Google Scholar]
  8. Brunner H., Greenberg H. B., James W. D., Horswood R. L., Couch R. B., Chanock R. M. Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers. Infect Immun. 1973 Oct;8(4):612–620. doi: 10.1128/iai.8.4.612-620.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Brunner H. Protective efficacy of Mycoplasma pneumoniae polysaccharides. Isr J Med Sci. 1981 Jul;17(7):678–681. [PubMed] [Google Scholar]
  10. COUCH R. B., CATE T. R., CHANOCK R. M. INFECTION WITH ARTIFICIALLY PROPAGATED EATON AGENT (MYCOPLASMA PNEUMONIAE). IMPLICATIONS FOR DEVELOPMENT OF ATTENUATED VACCINE FOR COLD AGGLUTININ-POSITIVE PNEUMONIA. JAMA. 1964 Feb 8;187:442–447. [PubMed] [Google Scholar]
  11. Chandler D. K., Barile M. F. Ciliostatic, hemagglutinating, and proteolytic activities in a cell extract of Mycoplasma pneumoniae. Infect Immun. 1980 Sep;29(3):1111–1116. doi: 10.1128/iai.29.3.1111-1116.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chandler D. K., Grabowski M. W., Rabson A. S., Barile M. F. Further studies on the Mycoplasma pneumoniae extract: ciliostatic and cell recruitment activities. Isr J Med Sci. 1987 Jun;23(6):580–584. [PubMed] [Google Scholar]
  13. Feldner J., Göbel U., Bredt W. Mycoplasma pneumoniae adhesin localized to tip structure by monoclonal antibody. Nature. 1982 Aug 19;298(5876):765–767. doi: 10.1038/298765a0. [DOI] [PubMed] [Google Scholar]
  14. Fernald G. W., Clyde W. A. Protective Effect of Vaccines in Experimental Mycoplasma pneumoniae Disease. Infect Immun. 1970 Jun;1(6):559–565. doi: 10.1128/iai.1.6.559-565.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fernald G. W. Immunologic aspects of experimental Mycoplasma pneumoniae infection. J Infect Dis. 1969 Mar;119(3):255–266. doi: 10.1093/infdis/119.3.255. [DOI] [PubMed] [Google Scholar]
  16. Freundt E. A. A collaborative assay of mycoplasma reference antisera. J Biol Stand. 1983 Jul;11(3):227–240. doi: 10.1016/s0092-1157(83)80010-9. [DOI] [PubMed] [Google Scholar]
  17. Gearhart P. J., Hurwitz J. L., Cebra J. J. Successive switching of antibody isotypes expressed within the lines of a B-cell clone. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5424–5428. doi: 10.1073/pnas.77.9.5424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Greenberg H., Helms C. M., Brunner H., Chanock R. M. Asymptomatic infection of adult volunteers with a temperature sensitive mutant of Mycoplasma pneumoniae. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4015–4019. doi: 10.1073/pnas.71.10.4015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Greenberg H., Helms C. M., Grizzard M. B., James W. D., Horswood R. L., Chanock R. M. Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of route of administration on the immunogenicity and protective effect of inactivated M. pneumoniae vaccine. Infect Immun. 1977 Apr;16(1):88–92. doi: 10.1128/iai.16.1.88-92.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Harboe N., Ingild A. Immunization, isolation of immunoglobulins, estimation of antibody titre. Scand J Immunol Suppl. 1973;1:161–164. doi: 10.1111/j.1365-3083.1973.tb03798.x. [DOI] [PubMed] [Google Scholar]
  21. Hayatsu E. Acquired immunity to Mycoplasma pneumoniae. Pneumonia in hamsters. Microbiol Immunol. 1978;22(4):181–195. doi: 10.1111/j.1348-0421.1978.tb00362.x. [DOI] [PubMed] [Google Scholar]
  22. Hayatsu E., Kawakubo Y., Yayoshi M., Araake M., Wakai M., Yoshida A., Yoshioka M., Nishiyama Y. Immunological responses of hamsters in the acquired immune state to Mycoplasma pneumoniae infection. Microbiol Immunol. 1981;25(12):1255–1263. doi: 10.1111/j.1348-0421.1981.tb00135.x. [DOI] [PubMed] [Google Scholar]
  23. Hu P. C., Cole R. M., Huang Y. S., Graham J. A., Gardner D. E., Collier A. M., Clyde W. A., Jr Mycoplasma pneumoniae infection: role of a surface protein in the attachment organelle. Science. 1982 Apr 16;216(4543):313–315. doi: 10.1126/science.6801766. [DOI] [PubMed] [Google Scholar]
  24. Jensen K. E., Senterfit L. B., Chanock R. M., Smith C. B., Purcell R. H. An inactivated mycoplasma pneumoniae vaccine. JAMA. 1965 Oct 18;194(3):248–252. [PubMed] [Google Scholar]
  25. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  26. Metzgar D. P., Woodhour A. F., Vella P. P., Weibel R. E., Stokes J., Jr, Drake M. E., Tytell A. A., Hilleman M. R. Respiratory virus vaccines. II. Mycoplasma pneumoniae (Eaton agent) vaccines. Am Rev Respir Dis. 1966 Jul;94(1):1–9. doi: 10.1164/arrd.1966.94.1.1. [DOI] [PubMed] [Google Scholar]
  27. Mogabgab W. J. Protective effects of inactive Mycoplasma pneumoniae vaccine in military personnel, 1964-1966. Am Rev Respir Dis. 1968 Mar;97(3):359–365. doi: 10.1164/arrd.1968.97.3.359. [DOI] [PubMed] [Google Scholar]
  28. Pierce N. F., Koster F. T. Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats. J Immunol. 1980 Jan;124(1):307–311. [PubMed] [Google Scholar]
  29. Razin S., Prescott B., Chanock R. M. Immunogenicity of Mycoplasma pneumoniae glycolipids: a novel approach to the production of antisera to membrane lipids. Proc Natl Acad Sci U S A. 1970 Oct;67(2):590–597. doi: 10.1073/pnas.67.2.590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Smith C. B., Chanock R. M., Friedewald W. T., Alford R. H. Mycoplasma pneumoniae infections in volunteers. Ann N Y Acad Sci. 1967 Jul 28;143(1):471–483. doi: 10.1111/j.1749-6632.1967.tb27691.x. [DOI] [PubMed] [Google Scholar]
  31. Smith C. B., Friedewald W. T., Chanock R. M. Inactivated Mycoplasma pneumoniae vaccine. Evaluation in volunteers. JAMA. 1967 Feb 6;199(6):353–358. [PubMed] [Google Scholar]
  32. Taylor-Robinson D., Purcell R. H., Wong D. C., Chanock R. M. A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) 1966 Mar;64(1):91–104. doi: 10.1017/s0022172400040377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wenzel R. P., Craven R. B., Davies J. A., Hendley J. O., Hamory B. H., Gwaltney J. M., Jr Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine. J Infect Dis. 1977 Aug;136 (Suppl):S204–S207. doi: 10.1093/infdis/136.supplement.s204. [DOI] [PubMed] [Google Scholar]
  34. Yayoshi M., Araake M., Hayatsu E., Takezawa T., Yoshioka M. Immunogenicity and protective effect of hemolysis mutants of Mycoplasma pneumoniae. Microbiol Immunol. 1985;29(11):1029–1037. doi: 10.1111/j.1348-0421.1985.tb00893.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES